Optimal compressive force induces bone formation via increasing bone sialoprotein and prostaglandin E2 production appropriately
Authors:
- Noriyoshi ShimizuNSNoriyoshi Shimizu
- 1 November 2005
- journal article
- Published by Elsevier in Life Sciences
- Vol. 77 (25) , 3168-3182
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Promotion and Mutual Aid Corporation for Private Schools of Japan
- Japan Society for the Promotion of Science (14571968)
This publication has 38 references indexed in Scilit:
- Osteopontin Expression in Osteoblasts and Osteocytes During Bone Formation Under Mechanical Stress in the Calvarial Suture In VivoJournal of Bone and Mineral Research, 2003
- Prostaglandin E2-Mediated Anabolic Effect of a Novel Inhibitor of Phosphodiesterase 4, XT-611, in the In Vitro Bone Marrow CultureJournal of Bone and Mineral Research, 2003
- Expression of the prostaglandin E2 (PGE2) receptor subtype EP4 and its regulation by PGE2 in osteoblastic cell lines and adult rat bone tissue11M.W. and M.M. contributed equally to this study.Bone, 2001
- OsteopontinCritical Reviews in Oral Biology & Medicine, 2000
- Differential Stimulation by PGE2 and Calcemic Hormones of IL-6 in Stromal/Osteoblastic CellsBiochemical and Biophysical Research Communications, 2000
- The role of prostaglandins and nitric oxide in the response of bone to mechanical forcesOsteoarthritis and Cartilage, 1999
- Bone SialoproteinCritical Reviews in Oral Biology & Medicine, 1999
- Immunohistochemical localization of bone sialoprotein in foetal porcine bone tissues: comparisons with secreted phosphoprotein 1 (SPP-1, osteopontin) and SPARC (osteonectin)Journal of Molecular Histology, 1991
- Macrophage colony stimulating factor (M-CSF) is essential for osteoclast formation in vitroBiochemical and Biophysical Research Communications, 1991
- The effects of indomethacin and verapamil on the shape changes of vascular endothelial cells resulting from exposure to various inflammatory agentsInflammation Research, 1988